Transcatheter Embolization and Occlusion Devices | Market Insights | Asia Pacific (Supplemental) | 2024
The Asia Pacific TEO device market will see moderate growth through 2032 driven by the launch and increasing adoption of new devices backed by favorable clinical data, increasing access to the TEO devices, and rising demand for TEO procedures among the expanding patient population due to the faster recovery and better cost-effectiveness associated with these minimally invasive devices. However, the ongoing cost constraints in the region will remain a challenge for this market.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for TEO devices in Asia Pacific from 2019 through 2032.
Related Medtech Insights Reports
Report
Transcatheter Embolization and Occlusion Devices | Market Insights | Latin America (Supplemental) | 2023
Although COVID-19 has negatively impacted the Latin American transcatheter embolization and occlusion device market, the impact of COVID-19 has been limited. The market will expand at a modest rate…
